Encompass Capital Advisors LLC
-4.15%
3個月報酬率
$2.030
-0.025 (-1.22%)收盤時
ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. Its proprietary technologies, the Aerodynamic Separation Process and Quantum Enrichment technology, are designed to enable the production of isotopes used in several industries. Its initial focus is on the production and commercialization of enriched Carbon-14 (C-14), Silicon-28 (Si-28) and Ytterbium-176 (Yb-176). It is also a provider of liquid helium with operations at the Virginia Gas Project in South Africa. Its nuclear fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its specialist isotopes and related services segment is focused on research and development of technologies and methods used to separate isotopes for highly specialized target end markets.
ASP Isotopes Inc is not a good buy right now due to its current price of 2.14, a very low RSI of 23.99 indicating oversold conditions, and a significant 5-day change of -19.25%. While there are positive catalysts such as a projected revenue of approximately $14 million for 2026, the risks associated with a high forward P/E and negative net income trends suggest caution.

Investigation into ASP Isotopes Shareholder Rights

ASP Isotopes Inc. Hosts Inaugural Capital Markets Day in London

Schedule Released for 95th Emerging Growth Conference

ASP Isotopes Reports Operational Progress Ahead of Q2 Results

Senators Demand Investigation into Trump Family Mineral Deals
ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. Its proprietary technologies, the Aerodynamic Separation Process and Quantum Enrichment technology, are designed to enable the production of isotopes used in several industries. Its initial focus is on the production and commercialization of enriched Carbon-14 (C-14), Silicon-28 (Si-28) and Ytterbium-176 (Yb-176). It is also a provider of liquid helium with operations at the Virginia Gas Project in South Africa. Its nuclear fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its specialist isotopes and related services segment is focused on research and development of technologies and methods used to separate isotopes for highly specialized target end markets. It operates in the Healthcare sector (MISCELLANEOUS CHEMICAL PRODUCTS industry).
ASP Isotopes Inc is not a good buy right now due to its current price of 2.14, a very low RSI of 23.99 indicating oversold conditions, and a significant 5-day change of -19.25%. While there are positive catalysts such as a projected revenue of approximately $14 million for 2026, the risks associated with a high forward P/E and negative net income trends suggest caution.

$ASPI If $1.9X doesn't hold either... I'm going to cry like a child. 🫣. Weekly chart.
展開
$ASPI Finally a decent weekly candle, a hammer candle at that horrible channel support.
展開

$ASPI Every year, I tend to have one weak spot in my portfolio. This year, it’s this one. What a disappointment! Monthly chart.
展開
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。